Department of Biomedical Sciences, SNU

Faculty

Faculty

Research

Research Field
Prof. Yu is interested in various fields related to personalized drug therapy, early phase clinical trials, pharmacokinetic-pharmacodynamic (PK-PD) modeling and clinical trial simulation, and also digital therapeutics
He is conducting many clinical research projects every year, spanning various kinds of trials such as first-time-in-human studies, PK-PD studies, drug-drug interaction studies, new formulation PK evaluations, clinical pharmacogenomic studies, PK-PD support in phase 2 or 3 trials, and also is giving many consultations regarding clinical pharmacotherapy and new drug development.
Keyword
Personalized Drug Therapy, Clinical Pharmacokinetics (PK) and Pharmacodynamics (PD), PK-PD modeling and Simulation, Therapeutic Drug Monitoring (TDM), Digital Therapeutics (DTx)
Intensive Major

Education

  • ㅡSeoul National University College of Medicine, Seoul, Korea : M.D.
  • ㅡ Seoul National University Graduate School, Seoul, Korea : Ph.D. in Clinical Pharmacology
  • ㅡYonsei Graduate School of Business, Seoul, Korea : M.B.A. in International Business

Career

  • Head Professor and Chair, Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital
  • Professor, Department of Biomedical Sciences, Seoul National University Graduate School of Medicine

Publication

  1. Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication. Br J Clin Pharmaco. 2021
  2. Home-based virtual reality for chronic pain: protocol for an NIH-supported randomised-controlled trial. BMJ 2021
  3. Population pharmacokinetic study of prophylactic fluconazole in preterm infants for prevention of invasive candidiasis. Antimicrobial Agents and Chemotherapy. 2019
  4. Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients. Bone Marrow Transplantation. 2019
  5. Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug–Drug Interaction Potentials. Pharmaceutical Research. 2018
  6. Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers. Drug Design, Development and Therapy. 2018